Indefinite Delivery Contract SPE2DR25D2007

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D2012 is a $999,999,999 single-award contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The IDC serves as a primary vehicle for DLA...
The Indefinite Delivery Contract (IDC) SPE2DR25D2917 is a $999,999,999 single-award contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a base period of 30 months and three 30-month option periods, running through December 2036. The purpose of this IDC is to establish Pharmaceutical Prime Vendor (PPV) Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the...
The Indefinite Delivery Contract (IDC) SPE2DX25D5000 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $999,999,999 and runs through March 2035. The purpose of this IDC is to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support,...
The Indefinite Delivery Contract (IDC) SPE2DR25D2018 is a $999,999,999 single-award contract issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract's purpose is to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This...
The Indefinite Delivery Contract (IDC) SPE2DR25D1116 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC has an ultimate completion date of December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The original...
The Indefinite Delivery Contract (IDC) SPE2DR25D1104 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a $9,999,999,999 ceiling value and runs through December 31, 2036. It serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical...
The Indefinite Delivery Contract (IDC) SPE2DR25D6035 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is a single-award IDC with a period of performance through December 31, 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including...
The Indefinite Delivery Contract (IDC) SPE2DR25D1002, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, is a single-award contract valued at $9,999,999,999 running through December 31, 2036. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
The Indefinite Delivery Contract (IDC) SPE2DU25D3130 is a single-award contract between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract covers a 30-month base period plus three 30-month option periods, through December 2036. The IDC aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including brand-name,...
The Indefinite Delivery Contract (IDC) SPE2DR25D2109 is a $999,999,999 contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. This IDC serves as a...

The Indefinite Delivery Contract (IDC) SPE2DR25D2007 is a single-award contract valued at $999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract has an ultimate completion date of December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, which aims to establish Prime Vendor Contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, the U.S. Coast Guard, Designated Providers, Other Government Agencies, and the U.S. Naval Fleet. The contracted products include specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract is structured as a firm-fixed price, requirements-type contract with a 30-month base period and three 30-month option periods. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items.

Generated 6/6/25, 10:14 AM